The Effect of Guided Imagery on the Third Stage of Labor

This study has been completed.
Sponsor:
Collaborators:
Sigma Theta Tau International, Iota chapter
Sigma Theta Tau International, Delta Psi chapter
American College of Nurse-Midwive - ACNM Foundation
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00826735
First received: January 20, 2009
Last updated: January 21, 2009
Last verified: January 2009

January 20, 2009
January 21, 2009
January 2007
December 2007   (final data collection date for primary outcome measure)
Blood Loss [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00826735 on ClinicalTrials.gov Archive Site
Length of third stage of labor [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
The Effect of Guided Imagery on the Third Stage of Labor
The Effect of Guided Imagery on the Third Stage of Labor

The purpose of this study was to evaluate the effect of guided imagery on the third stage of labor. Blood loss from hemorrhage during childbirth, most commonly due to uterine atony, is one of the leading causes of maternal mortality in the United States and the leading cause of maternal death worldwide. The hypothesis was that the use of physiologic guided imagery would reduce the amount of bleeding during the third stage of labor.

Not Provided
Interventional
Not Provided
Primary Purpose: Prevention
  • Third Stage of Labor
  • Bleeding
  • Guided Imagery
  • Childbirth
Behavioral: Guided imagery
A relaxation focused guided imagery intervention was used through the remainder of pregnancy plus a physiologic guided imagery intervention was used during the third stage of labor.
Experimental: Guided imagery
The experimental group received a relaxation focused guided imagery intervention to use through the remainder of pregnancy plus a physiologic guided imagery intervention during the third stage of labor. These interventions were scripted and prerecorded on CDs.
Intervention: Behavioral: Guided imagery
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
December 2007
December 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 years of age or older but less than 35 years
  • English as her primary language
  • fetus in a cephalic presentation
  • singleton pregnancy
  • 36 to 38 estimated gestational weeks
  • no contraindications to vaginal delivery
  • maternal weight less than 200 pounds prior to pregnancy

Exclusion Criteria:

  • more than four previous children
  • a history of postpartum hemorrhage
  • bleeding disorder
  • seizure disorder
  • polyhydramnios
  • diabetes (including gestational)
  • hypertension
  • cardiac disease
  • uterine fibroids
  • anemia (hematocrit less than 30)
  • intrauterine fetal demise or tobacco use
Female
18 Years to 34 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00826735
070035
No
Mavis N. Schorn RN, CNM, PhD, Vanderbilt University School of Nursing
Vanderbilt University
  • Sigma Theta Tau International, Iota chapter
  • Sigma Theta Tau International, Delta Psi chapter
  • American College of Nurse-Midwive - ACNM Foundation
Principal Investigator: Mavis N Schorn, PhD Vanderbilt University School of Nursing
Vanderbilt University
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP